Glenmark brings relief with FabiFlu, priced @ Rs 103 a tablet
Glenmark brings relief with FabiFlu, priced @ Rs 103 a tablet: Glenmark developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fast track trials with Phase III in limited patients; approval process is also under Emergency Use Authorisation. The drug acts by getting into cells and inhibit the activity of viral replication to reduce the viral load.
Comments
Post a Comment